MetaTOC stay on top of your field, easily

Investigation of morin‐induced insulin secretion in cultured pancreatic cells

, , , ,

Clinical and Experimental Pharmacology and Physiology

Published online on


Morin is a flavonoid contained in guava that is known to reduce hyperglycemia in diabetes. Insulin secretion has been demonstrated to increase following the administration of morin. The present study is designed to investigate the potential mechanism(s) of morin‐induced insulin secretion in the MIN6 cell line. First, we identified that morin induced a dose‐dependent increase in insulin secretion and intracellular calcium content in MIN6 cells. Morin potentiated glucose‐stimulated insulin secretion (GSIS). Additionally, we used siRNA for the ablation of imidazoline receptor protein (NISCH) expression in MIN6 cells. Interestingly, the effects of increased insulin secretion by morin and canavanine were markedly reduced in Si‐NISCH cells. Moreover, we used KU14R to block imidazoline I3 receptor (I‐3R) that is known to enhance insulin release from the pancreatic β‐cells. Without influence on the basal insulin secretion, KU14R dose‐dependently inhibited the increased insulin secretion induced by morin or efaroxan in MIN6 cells. Additionally, effects of increased insulin secretion by morin or efaroxan were reduced by diazoxide at the dose sufficient to open KATP channels and attenuated by nifedipine at the dose used to inhibit L‐type calcium channels. Otherwise, phospholipase C (PLC) is introduced to couple with imidazoline receptor (I‐R). The PLC inhibitor dose‐dependently inhibited the effects of morin in MIN6 cells. Similar blockade was also observed in protein kinase C (PKC) inhibitor‐treated cells. Taken together, we found that morin increases insulin secretion via the activation of I‐R in pancreatic cells. Therefore, morin would be useful to develop in the research and treatment of diabetic disorders.